{"filings":[{"id":119437,"accession_number":"0001683168-25-008521","cik":1355790,"company_name":"International Stem Cell CORP","ticker":"ISCO","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"International Stem Cell reports annual meeting voting results","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All four director nominees elected: Semechkin and Kern (Series D), Wright and Maier (all shares) with 7.77M votes each.","Advisory vote on executive compensation approved: 7,715,844 for, 73,393 against, 2,459 abstain.","Advisory vote on frequency of say-on-pay selected '3 Years' with 7,593,833 votes; 1-year and 2-year received 142,581 and 50,443 votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1360746.1621621621,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135995,"accession_number":"0001683168-25-007018","cik":1355790,"company_name":"International Stem Cell CORP","ticker":"ISCO","form_type":"8-K","filed_at":"2025-09-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"International Stem Cell extends CEO loan of $2.5M to Sept 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extended maturity of $2.5M promissory note from CEO Andrey Semechkin from Sept 15, 2025 to Sept 15, 2026.","Original note was $2.7M issued Sept 2024; $200k repaid; outstanding principal $2.5M.","Accrued and unpaid interest of $799,064.44 carried forward, does not accrue additional interest.","Interest rate unchanged at 5.5% per annum; company may prepay without penalty.","Company's Co-Chairman and CEO is the noteholder; related-party transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1360746.1621621621,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205295,"accession_number":"0001683168-24-006436","cik":1355790,"company_name":"International Stem Cell CORP","ticker":"ISCO","form_type":"8-K","filed_at":"2024-09-17T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"International Stem Cell extends CEO's $2.7M loan maturity to Sept 2025 after repaying $200k","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["CEO Dr. Andrey Semechkin loan of $2.9M extended; $200k repaid, new $2.7M unsecured note issued.","New note bears 5.5% interest, matures Sept 15, 2025, prepayable without penalty.","Accrued unpaid interest of ~$645k from prior note remains outstanding.","Related-party transaction creates direct financial obligation; Noteholder is Co-Chairman and CEO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1360746.1621621621,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}